School of Pharmaceutical Sciences, Shandong University, No.44 Wenhuaxi Road, Jinan 250012, China.
Zibo Institute for Food and Drug Control, Zibo 255086, China.
J Chromatogr A. 2020 Jun 7;1620:460988. doi: 10.1016/j.chroma.2020.460988. Epub 2020 Feb 21.
Traditional Chinese medicine (TCM), especially herbal medicine compound preparation, faces great challenges in its quality control due to a myriad of components involved. How to perform quality control of TCM more effectively has been a research topic. In this study, we used Tianmeng oral liquid (TOL) as a case study and developed a comprehensive strategy based on non-targeted, targeted and bioactive analyses for quality evaluation of TOL from different batches. Firstly, a non-targeted fingerprinting analysis was performed by HPLC-DAD and UHPLC-MS/MS. Twenty-five batches of TOL were clearly discriminated by similarity analysis and hierarchical cluster analysis and components were tentatively identified. Secondly, the targeted quantitative methods based on HPLC-DAD and HPLC-MS were applied to simultaneous quantitative determination of five and eight marker compounds, especially toxic component strychnine, respectively. The quantitative data were processed with principal component analysis for differentiating different batches of samples. Finally, we explored the feasibility of establishing a total antioxidant capacity (TAC) model. How to use the peak area instead of the corresponding concentration to determine the antioxidant activity-related compounds was theoretically explained for the first time, which was of great significance for the study of the fingerprint-efficacy relationship. The orthogonal signal correction-partial least squares model was employed to predict the TAC of TOL from their chromatographic fingerprints and identify three potential antioxidant markers. These results demonstrated that the comprehensive strategy from fingerprinting, chemical composition, multiple-component quantification, and antioxidant activity could be applied to quality evaluation of TOL and discrimination of the expired and unexpired samples.
中药(TCM),特别是草药复方制剂,由于涉及到众多成分,其质量控制面临巨大挑战。如何更有效地进行中药质量控制一直是研究课题。本研究以天梦口服液(TOL)为实例,建立了一种基于非靶向、靶向和生物活性分析的综合策略,用于评价不同批次 TOL 的质量。首先,采用 HPLC-DAD 和 UHPLC-MS/MS 进行非靶向指纹图谱分析。通过相似度分析和层次聚类分析,25 批 TOL 得到了明显区分,并对成分进行了初步鉴定。其次,采用 HPLC-DAD 和 HPLC-MS 建立了 5 个和 8 个标记物(特别是有毒成分士的宁)的同时定量方法,用于定量测定。采用主成分分析对不同批次的样品进行了区分。最后,我们探索了建立总抗氧化能力(TAC)模型的可行性。首次从理论上解释了如何使用峰面积而不是相应浓度来确定与抗氧化活性相关的化合物,这对于指纹-功效关系的研究具有重要意义。采用正交信号校正-偏最小二乘模型来预测 TOL 的 TAC,并鉴定出 3 个潜在的抗氧化标记物。结果表明,指纹图谱、化学成分、多成分定量和抗氧化活性的综合策略可用于 TOL 的质量评价和过期与未过期样品的鉴别。